Engineered biosynthesis of plant polyketides by type III polyketide synthases in microorganisms
- PMID: 36312548
- PMCID: PMC9614166
- DOI: 10.3389/fbioe.2022.1017190
Engineered biosynthesis of plant polyketides by type III polyketide synthases in microorganisms
Erratum in
-
Corrigendum: Engineered biosynthesis of plant polyketides by type III polyketide synthases in microorganisms.Front Bioeng Biotechnol. 2022 Nov 22;10:1094116. doi: 10.3389/fbioe.2022.1094116. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36483779 Free PMC article.
Abstract
Plant specialized metabolites occupy unique therapeutic niches in human medicine. A large family of plant specialized metabolites, namely plant polyketides, exhibit diverse and remarkable pharmaceutical properties and thereby great biomanufacturing potential. A growing body of studies has focused on plant polyketide synthesis using plant type III polyketide synthases (PKSs), such as flavonoids, stilbenes, benzalacetones, curcuminoids, chromones, acridones, xanthones, and pyrones. Microbial expression of plant type III PKSs and related biosynthetic pathways in workhorse microorganisms, such as Saccharomyces cerevisiae, Escherichia coli, and Yarrowia lipolytica, have led to the complete biosynthesis of multiple plant polyketides, such as flavonoids and stilbenes, from simple carbohydrates using different metabolic engineering approaches. Additionally, advanced biosynthesis techniques led to the biosynthesis of novel and complex plant polyketides synthesized by diversified type III PKSs. This review will summarize efforts in the past 10 years in type III PKS-catalyzed natural product biosynthesis in microorganisms, especially the complete biosynthesis strategies and achievements.
Keywords: biosynthesis achievements; biosynthesis strategies; complete biosynthesis; microorganisms; plant polyketides; type III polyketide synthases.
Copyright © 2022 Liu and Li.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous